The role of protein oxidation and DNA damage in elderly hypertension

Aging Clinical and Experimental Research

Volumn 28, Issue 4, 2016, Pages 625-632

  Yavuzer, Serap ^a   Yavuzer, Hakan ^a   Cengiz, Mahir ^a   Erman, Hayriye ^a   Demirdag, Filiz ^a   Doventas, Alper ^a   Balci, Huriye ^a   Erdincler, Deniz Suna ^a   Uzun, Hafize ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Aging; DNA damage; Hypertension; Oxidative stress; Protein oxidation

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADVANCED OXIDATION PROTEIN PRODUCT; FREE RADICAL; ISCHEMIA MODIFIED ALBUMIN; PLASMA PROTEIN; PROTEIN CARBONYL; THIOL; UNCLASSIFIED DRUG; 8-OXO-7-HYDRODEOXYGUANOSINE; ANTIOXIDANT; BIOLOGICAL MARKER; DEOXYGUANOSINE; ISCHEMIA-MODIFIED ALBUMIN; SERUM ALBUMIN; THIOL DERIVATIVE;

ADULT; AGED; AGING; ARTICLE; CELL DAMAGE; CELLULAR PARAMETERS; CONTROLLED STUDY; DNA DAMAGE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OXIDATION; OXIDATIVE STRESS; PROOXIDANT ANTIOXIDANT BALANCE; ANALOGS AND DERIVATIVES; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIOXIDANTS; BIOMARKERS; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; FREE RADICALS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; SERUM ALBUMIN; SULFHYDRYL COMPOUNDS;

EID: 84944930029     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-015-0464-7     Document Type: Article

References (30)

1. Logan AG (2011) Hypertension in aging patients. Expert Rev Cardiovasc Ther 9:113–120
2. Cakatay U, Kayali R, Uzun H (2008) Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population. Clin Exp Med 8:51–57
3. Beckman KB, Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78:547–581
4. Rubio-Ruiz ME, Pérez-Torres I, Soto ME et al (2014) Aging in blood vessels. Medicinal agents FOR systemic arterial hypertension in the elderly. Ageing Res Rev 18:132–147
5. Reaven PD, Napoli C, Merat S et al (2000) Lipoprotein modification and atherosclerosis in aging. Exp Gerontol 34:527–537
6. Seres I, Paragh G, Deschene E et al (2004) Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol 39:59–66
7. Dincer Y, Sekercioglu N, Pekpak M et al (2008) Assessment of DNA oxidation and antioxidant activity in hypertensive patients with chronic kidney disease. Ren Fail 30(10):1006–1011
8. Hu ML (1994) Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233:381–385
9. Gelisgen R, Genc H, Kayali R et al (2011) Protein oxidation markers in women with and without gestational diabetes mellitus: a possible relation with paraoxonase activity. Diabetes Res Clin Pract 94:404–409
10. Alamdari DH, Ghayour-Mobarhan M, Tavallaie S et al (2008) Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem 41:375–380
11. American Diabetes Association (2003) Diabetic nephropathy. Diabetes Care 26(Suppl 1):S94–S98
12. Nakamoto H, Kaneko T, Tahara S et al (2007) Regular exercise reduces 8-oxodG in the nuclear and mitochondrial DNA and modulates the DNA repair activity in the liver of old rats. Exp Gerontol 42:287–295
13. Berlett BS, Stadtman ER (1997) Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272:20313–20316
14. Stadtman ER (2001) Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci 928:22–38
15. Çakatay U, Kayali R (2005) Plasma protein oxidation in aging rats after alpha-lipoic acid administration. Biogerontology 6:87–93
16. Young IS, Woodside JV (2001) Antioxidants in health and disease. J Clin Pathol 54:176–186
17. Salive ME, Cornoni-Huntley J, Phillips CL et al (1992) Serum albumin in older persons: relationship with age and health status. J Clin Epidemiol 45:213–221
18. Gom I, Fukushima H, Shiraki M et al (2007) Relationship between serum albumin level and aging in community-dwelling self-supported elderly population. J Nutr Sci Vitaminol 53:37–42
19. Campion EW, deLabry LO, Glynn RJ (1988) The effect of age on serum albumin in healthy males: report from the Normative Aging Study. J Gerontol 43:M18–M20
20. Caner M, Karter Y, Uzun H et al (2006) Oxidative stress in human in sustained and white coat hypertension. Int J Clin Pract 60:1565–1571
21. Agarwal S, Sohal RS (1993) Relationship between aging and susceptibility to protein oxidative damage. Biochem Biophys Res Commun 194:1203–1206
22. Sohal RS, Agarwal S, Sohal BH (1995) Oxidative stress and aging in the Mongolian gerbil (Meriones unguiculatus). Mech Ageing Dev 81:15–25
23. Piwowar A, Knapik-Kordecka M, Warwas M (2008) Ischemia-modified albumin level in type 2 diabetes mellitus: preliminary report. Dis Markers 24:311–317
24. Roy D, Quiles J, Gaze DC et al (2006) Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 92:113–114
25. Toker A, Mehmetoglu I, Yerlikaya FH et al (2013) Investigation of oxidative stress markers in essential hypertension. Clin Lab 59:107–114
26. Kim JY, Prouty LA, Fang SC et al (2009) Association between fine particulate matter and oxidative DNA damage may be modified in individuals with hypertension. J Occup Environ Med 51:1158–1166
27. Negishi H, Ikeda K, Kuga S et al (2001) The relation of oxidative DNA damage to hypertension and other cardiovascular risk factors in Tanzania. J Hypertens 19:529–533
28. Loft S, Vistisen K, Ewertz M et al (1992) Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 132:2241–2247
29. Subash P, Gurumurthy P, Sarasabharathi A et al (2010) Urinary 8-OHdG: a marker of oxidative stress to DNA and total antioxidant status in essential hypertension with South Indian population. Indian J Clin Biochem 25:127–132
30. Izzo JL Jr (2001) Aging and systolic hypertension: cluster patterns and problem-solving strategies to answer the genetic riddle. Hypertension 37:1067–1068